18F-Fluoromisonidazole in tumor hypoxia imaging

58Citations
Citations of this article
73Readers
Mendeley users who have this article in their library.

Abstract

Hypoxia is a common feature of solid tumors that is closely associated with radiotherapy and chemotherapy resistance, metastasis and tumors prognosis. Thus, it is important to assess hypoxia in tumors for estimating prognosis and selecting appropriate treatment procedures. 18F-Fluoromisonidazole positron emission tomography (18F-FMISO PET) has been widely used to visualize tumor hypoxia in a comprehensive and noninvasive way, both in the clinical and preclinical settings. Here we review the concept, mechanisms and detection methods of tumor hypoxia. Furthermore, we discuss the correlation between 18F-FMISO PET and other detection methods, current applications of 18F-FMISO PET and the development prospects of this imaging technology.

Cite

CITATION STYLE

APA

Xu, Z., Li, X. F., Zou, H., Sun, X., & Shen, B. (2017, November 1). 18F-Fluoromisonidazole in tumor hypoxia imaging. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.21662

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free